Drug Trial Radar · NCT05202327
PDC-1421 Treatment in Adult Patients With ADHD
Last checked: Nov 20, 2026Latest source record: May 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
99
Actual
Start
Apr 7, 2022
Primary completion
Dec 6, 2023
Study completion Apr 8, 2024
Sponsor
- Lead sponsor
- BioLite, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- ABVC BioPharma, Inc.
- First posted
- Jan 21, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Part II is a double-blind, randomized, parallel-group, placebo-controlled study. The primary objective of this trial is to determine the effective doses and treatment period of PDC-1421 Capsule in subjects with ADHD. The secondary objective is to evaluate the safety of PDC-1421 Capsule in subjects receiving PDC-1421 at various dose levels.
Conditions
- Attention-Deficit Hyperactivity Disorder (ADHD)
Interventions
PDC-1421 CapsuleDrug
PDC-1421 Capsule is a botanical investigational new drug containing the extract of Radix Polygalae (Polygala tenuifolia Willd.) as the active ingredient.
PlaceboDrug
The placebo contained corn starch.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Improvement ≥ 40% in ADHD-RS-IV From Baseline up to 8 Weeks TreatmentTime frame: 8 weeks
Locations
6 sites in 2 countries. Site status is shown where the registry gives one.
University of California, San Francisco
San Francisco, California
Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City, Taiwan
National Taiwan University Hospital
Taipei, Taiwan
Cheng Hsin General Hospital
Taipei, Taiwan
Taipei veterans General Hospital
Taipei, Taiwan
Linkou chang Gung Memorial Hospital
Taoyuan, Taiwan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.